KC Small Business Grant

The Invention Incentive Program is part of Rhode Island Commerce’s Innovation Initiatives Portfolio created to support local small businesses and innovators in Rhode Island, offering reimbursable grants up to $5,000 for eligible expenses incurred when filing patents.

The Prudential Community Grants Program provides Newark, New Jersey small businesses, individuals, and nonprofit organizations with microgrants of up to $2,500 (for individuals and small business owners applying as individuals) or up to $5,000 (for 501(c)(3) organizations or those with a fiscal sponsor) to support projects that create vibrancy in Newark's neighborhoods. Administered in collaboration between Prudential Financial, a global financial services company headquartered in Newark, and the Community Foundation of New Jersey (CFNJ), the program recognizes that local changemakers and business owners often have the solutions to strengthen their neighborhoods but frequently lack access to the financial resources needed to bring those ideas to life. To qualify, applicants must create neighborhood-level impact in the city of Newark, be willing to share impact stories including photos or videos as a result of the funding, be able to identify how the funding will be utilized, and secure a Statement of Community Support from a community resident as part of the application. Small business owners are required to apply as individuals rather than as businesses (small businesses, including brick-and-mortar entities, remain eligible under the individual track). Each applicant is limited to one application per cycle. Previous Prudential Community Grants Program awardees are eligible to reapply, but other Prudential grantees are not eligible for this specific program.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes.

The Workplace Accessibility Grant Program promotes employment and economic opportunity for individuals with disabilities through investment in accessible workplaces. It provides a 100% reimbursement for eligible costs up to $5,000 per calendar year. All Rhode Island employers with fewer than twenty-five (25) employees and who meet the eligibility requirements outlined in the program guide may apply.

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs. Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants. The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.